Product Information
AUROVELA FE 1.5 MG-30 MCG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1419 per EA under NDC 65862094188. Its NADAC has been published 372 times since Aug 21, 2019.
FDA first approved this application on Jun 15, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AUROVELA FE 1.5 MG-30 MCG TAB
Norethindrone Acetate and Ethinyl Estradiol and Ferrous FumarateManufacturer
Aurobindo Pharma LimitedNDC
65862094188
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA207580FDA Approved
6/15/2017
TE Code
AB
On Market Since
6/15/2017
Price Statistics
The NADAC for AUROVELA FE 1.5 MG-30 MCG TAB has been published 372 times since Aug 21, 2019, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1419 per EA |
|---|---|
| All-time high | $0.3905 (Apr 15, 2020) |
| All-time low | $0.1170 (May 22, 2024) |
| 52-week high | $0.1575 |
| 52-week low | $0.1303 |
| Median price | $0.1800 |
| Average price | $0.2244 |
| Largest weekly change | +29.4% (Jun 19, 2024) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AUROVELA FE 1.5 MG-30 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AUROVELA FE 1.5 MG-30 MCG TAB, manufactured by Aurobindo Pharma Limited, is $0.1419 per EA (NDC 65862094188), effective Sep 30, 2026.
How has the price of AUROVELA FE 1.5 MG-30 MCG TAB changed over time?
Over the history we have for it, the NADAC for AUROVELA FE 1.5 MG-30 MCG TAB has declined 58.3%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for AUROVELA FE 1.5 MG-30 MCG TAB?
Since Aug 21, 2019, the NADAC for AUROVELA FE 1.5 MG-30 MCG TAB has ranged from a low of $0.1170 (May 22, 2024) to a high of $0.3905 (Apr 15, 2020), with a median of $0.1800 per EA.
Are there cheaper alternatives to AUROVELA FE 1.5 MG-30 MCG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TARINA FE 1-20 EQ TABLET, is $0.1287 per EA — about 9% below AUROVELA FE 1.5 MG-30 MCG TAB.
Who manufactures AUROVELA FE 1.5 MG-30 MCG TAB?
AUROVELA FE 1.5 MG-30 MCG TAB (NDC 65862094188) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.